In clinical studies, data on associations of the APOL1 renal risk variants with cardiovascular disease have been complex, with evidence for increased risk [22, 23] and also with decreased carotid artery calcified plaque and improved survival [24]. Here, APOL1 is linked to cardiovascular disorder.